Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia

Hazar V., Tezcan Karasu G., ozturk G., Kupesiz A., AKSOYLAR S., ozbek N., ...More

PEDIATRIC TRANSPLANTATION, vol.25, no.5, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 5
  • Publication Date: 2021
  • Doi Number: 10.1111/petr.13942
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Keywords: acute leukemia, children, post&#8208, transplant relapse, treatment, BONE-MARROW-TRANSPLANTATION, ACUTE LYMPHOBLASTIC-LEUKEMIA, DONOR LEUKOCYTE INFUSIONS, OUTCOMES, GREFFE, MOELLE, EBMT, SCT
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes


Background Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Data on risk factors, treatment options, and outcomes are limited.